Gmp car-T cell production

AP Gee - Best Practice & Research Clinical Haematology, 2018 - Elsevier
The clinical success achieved using CD19-directed CAR-T cells has stimulated many
academic institutions to explore the feasibility of manufacturing these, and other CAR-T …

Regulations and guidelines governing stem cell based products: clinical considerations

B George - Perspectives in clinical research, 2011 - journals.lww.com
The use of stem cells as medicines is a promising and upcoming area of research as they
may be able to help the body to regenerate damaged or lost tissue in a host of diseases like …

[图书][B] Commercializing successful biomedical technologies

SS Mehta - 2022 - books.google.com
Transform your research into commercial biomedical products with this revised and updated
second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step …

[HTML][HTML] Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment

S Turcotte, M Donia, B Gastman… - Journal for …, 2025 - pmc.ncbi.nlm.nih.gov
In a first for solid cancers, cellular immunotherapy has entered standard of care in the
treatment of patients with metastatic melanoma. The infusion of autologous tumor-infiltrating …

GMP facilities for manufacturing of advanced therapy medicinal products for clinical trials: an overview for clinical researchers

E Alici, P Blomberg - Current gene therapy, 2010 - ingentaconnect.com
To be able to produce advanced therapy medicinal products, compliance with regulatory
standards while maintaining flexibility is mandatory. For this purpose, careful planning is …

Environmental Monitoring of cGMP Cleanroom Facilities for Manufacturing of Cellular Therapy Products in an Academic Hospital Setting

J Tanna, CD McCann, R Smith, A Pitino, A Asgedom… - Cytotherapy, 2024 - Elsevier
As the field of cell and gene therapy continues to grow, so too must the infrastructure and
regulatory guidance supporting the manufacture of these potentially life-saving products …

[HTML][HTML] An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade …

D Wood, R Wesselschmidt, P Hematti… - Clinical and …, 2014 - ncbi.nlm.nih.gov
Initially consisting of three cell processing facilities, PACT was expanded in 2010 to meet the
increasing needs of the scientific community. Currently, 5 cell processing facilities are …

The importance of cleanroom facility in manufacturing biomedical products

S Alavi-Moghadam, M Sarvari, P Goodarzi… - … Development: Bench to …, 2020 - Springer
The Importance of Cleanroom Facility in Manufacturing Biomedical Products | SpringerLink
Skip to main content Advertisement SpringerLink Account Menu Find a journal Publish with …

[图书][B] From Biotechnology To Bioindustry

SW Kim, KY Kim - 2019 - books.google.com
전 세계 주요국들에서 보건의료, 에너지, 환경 분야는 국가 안보와도 밀접하게 연결되어 있는
만큼 중점 사업으로 막대한 투자를 아끼지 않고 있다. 이에 힘입어 이들 분야 산업은 급속히 …

Aporte del químico farmacéutico a los desafíos relacionados con el desarrollo de productos de terapias avanzadas en Colombia

NA Jaimes Vega, RA Jiménez Cruz - 2019 - repository.udca.edu.co
APORTE DEL QUÍMICO FARMACÉUTICO A LOS DESAFÍOS RELACIONADOS CON EL
DESARROLLO DE PRODUCTOS DE TERAPIAS AVANZADAS EN COLOMBIA Page 1 Proyecto …